miR-484 sensitizes in IDH-wild and IDH-mutant glioblastoma cells to temozolomide by inhibiting oncogenic FOXM1 signaling

Nursultan Nurdinov, Ahsen Güler, Serhat Albayrak, Gizem Kursunluoglu, Halil Ulutabanca, Venhar Cınar, Mehmet Memis, Serife Erdem, Omer Aydın, Elif Funda Sener, Serpil Taheri, Bulent Ozpolat, Zuhal Hamurcu

Open source

DOI
10.1186/s12935-026-04238-x
Published
2026-04-01
Container
Cancer Cell International
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12935-026-04238-x,
  title = {miR-484 sensitizes in IDH-wild and IDH-mutant glioblastoma cells to temozolomide by inhibiting oncogenic FOXM1 signaling},
  author = {Nursultan Nurdinov and Ahsen Güler and Serhat Albayrak and Gizem Kursunluoglu and Halil Ulutabanca and Venhar Cınar and Mehmet Memis and Serife Erdem and Omer Aydın and Elif Funda Sener and Serpil Taheri and Bulent Ozpolat and Zuhal Hamurcu},
  year = {2026},
  journal = {Cancer Cell International},
  doi = {10.1186/s12935-026-04238-x},
  url = {https://doi.org/10.1186/s12935-026-04238-x}
}

RIS

TY  - JOUR
TI  - miR-484 sensitizes in IDH-wild and IDH-mutant glioblastoma cells to temozolomide by inhibiting oncogenic FOXM1 signaling
AU  - Nursultan Nurdinov
AU  - Ahsen Güler
AU  - Serhat Albayrak
AU  - Gizem Kursunluoglu
AU  - Halil Ulutabanca
AU  - Venhar Cınar
AU  - Mehmet Memis
AU  - Serife Erdem
AU  - Omer Aydın
AU  - Elif Funda Sener
AU  - Serpil Taheri
AU  - Bulent Ozpolat
AU  - Zuhal Hamurcu
PY  - 2026
JO  - Cancer Cell International
DO  - 10.1186/s12935-026-04238-x
UR  - https://doi.org/10.1186/s12935-026-04238-x
ER  - 

APA

Nurdinov, N., Güler, A., Albayrak, S., Kursunluoglu, G., Ulutabanca, H., Cınar, V., Memis, M., Erdem, S., Aydın, O., Sener, E. F., Taheri, S., Ozpolat, B., & Hamurcu, Z. (2026). miR-484 sensitizes in IDH-wild and IDH-mutant glioblastoma cells to temozolomide by inhibiting oncogenic FOXM1 signaling. Cancer Cell International. https://doi.org/10.1186/s12935-026-04238-x

Source records